Ivabradine

This classification denotes an antiarrhythmic agent with the molecular formula C27H36N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 3H48L0LPZQ, chemically known as 7,8-dimethoxy-3-(3-(((4,5-dimethoxybenzocyclobutan-1-yl)methyl)methylamino)propyl)-1,3,4,5-tetrahydro-2h-benzazepin-2-one but more generally known as ivabradine, which bears US NIH Compound Identifier 132999. European Medicines Agency schedules Ivabradine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08357MIG. The term IVABRADINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 11, No. 11997, List 37). World Health Organization schedules ivabradine in its Anatomical Therapeutic Chemical (ATC) Classification. IVABRADINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule ivabradine under HS 29337900 and SITC 51561. As of Q4 2014, IVABRADINE remains US FDA's Preferred Term for this commodity. Ivabradine bears US NLM identifiers UMLS ID C0257190 and NCI Concept Code C65995. SMILES: O(C1CC2C(CC2CC1OC)CN(CCCN1CCC2C(CC1=O)CC(OC)C(OC)C2)C)C.